FoRx raised a €10M seed round to develop a pipeline of next-gen cancer drugs focused on novel DNA Replication Stress (DRS) pathways.

Investors include $MRK M Ventures, $NVS Venture Fund, $PFE Ventures, Omega &amp; LSP.

https://t.co/LphrkxsTYt